Wabe, Fe C.
HRN: 13-63-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2022
CEFAZOLIN 1GM (VIAL)
07/03/2022
07/05/2022
IV
2grams
Q8 X 7 Doses
S/p Pelvic Lap
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes